PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists blaze new path to fighting viral diseases

Mapping vulnerabilities in the SARS-CoV-2 genome, made of RNA, reveals a path to fighting more than COVID-19

2025-10-06
(Press-News.org) JUPITER, Fla. — In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus that causes COVID-19.

In the process, the team devised a powerful new platform for finding medicines to fight many types of infectious diseases.

Writing in the Journal of the American Chemical Society, in an online article posted on Monday, Oct. 6, 2025, the scientists said they began by seeking “druggable pockets” in the stable structures of viral genetic material. Like keyholes, these pockets offer promising spaces to intervene with a precise medication. The team then used systematic chemistry, computational, and robotic drug discovery methods to find and perfect compounds able to function like the keys.

Their refined and optimized compound, dubbed Compound 6, led SARS-CoV-2 viral proteins to misfold, malfunction, and ultimately, be destroyed and removed by cells, in lab tests. Notably, their work could benefit other viral diseases, too, said Matthew D. Disney, Ph.D., Institute Professor and Chair of the chemistry department at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology.

“The method we have developed can be applied to any number of RNA-based viruses that burden society and have limited treatment options, including influenza, norovirus, MERS, Marburg, Ebola, Zika and more,” Disney said. “We have already started work on several of these.” 

Disney’s collaborators included Arnab Chatterjee, Ph.D., senior vice president of medicinal chemistry at the Skaggs-Calibr Institute for Innovative Medicines, in LaJolla, Calif., and Sumit Chanda, Ph.D., who headed the Center for Antiviral Medicines & Pandemic Preparedness at Scripps Research, part of the National Institutes of Health’s initiative to rebuild the nation’s antiviral medicine cabinet.

“This platform represents a transformative way of thinking about drug discovery,” Chatterjee said. “It has given us a roadmap not only to design antivirals for coronaviruses, but to rapidly extend this strategy to other high-priority RNA targets across infectious disease and beyond.”

The co-first authors were Sandra Kovachka, Ph.D., and Amirhossein Taghavi, Ph.D., of The Wertheim UF Scripps Institute, and Jielei Wang, a graduate student in Disney’s lab.

The SARS-CoV-2 virus is so tiny it would take 1,000 of them lined end-to-end to equal the width of a typical human hair. Still, its string-like genome packs instructions that trick infected cells into making 27 proteins.

One of them, a mechanism called a frameshift element, enables efficient use of the tight viral real estate. The frameshifter looks like a lever and functions much like an engine’s clutch or a 10-speed bike’s derailer. It causes the cell’s protein-building machines to pause while reading the virus’s genome. It then forces the machines to shift their protein-construction starting point, thus directing the cell to assemble a brand new protein for viral replication.

Disney reasoned that this frameshift element, conserved across the many variants of SARS-CoV-2, would serve as an ideal target for an RNA-focused drug.

Until recently, RNA structures have been viewed by scientists as especially challenging drug targets. Disney’s group has long focused on finding RNA structures that are readily druggable, as well as technologies and compound libraries to accomplish that goal, enabling them to make rapid progress.

In the new paper, Disney’s team used both computational and experimental approaches to find the right chemical probes that would allow the team to map the frameshift element’s binding pockets and mutations. Those methods included one Disney invented called Chem-CLIP, or Chemical Cross-Linking and Isolation by Pull-down, helpful for mapping drug-binding pockets.

Further analysis and experimentation revealed that a known compound, mirafloxacin, interfered with assembly of the frameshift element, though not optimally. Robotic high-throughput compound discovery revealed eight related chemical scaffolds that could bind to the mapped structures in a similar fashion. Their antiviral activity was confirmed through experiments on live cells infected with SARS-CoV-2. They found Compound 6 had the optimal impact. Ahead, the team is developing strategies to boost the potency and effectiveness of Compound 6.

Most gratifying about this collaboration, Disney said, is that the team showed how blending expertise and technologies systematically produced a powerful new way to attack viral diseases that have RNA as their genetic basis.

“This strategy offers a directed and unbiased way to rationally design RNA-targeting antiviral small-molecule medications,” said Disney, who directs the institute’s center of excellence, RNA: From Biology to Drug Discovery. “By linking deep structural biology expertise with drug discovery capabilities, we are accelerating the path from basic RNA biology to potential medicines.”

Chanda, whose team conducted the cell-based tests, said this project also demonstrated the rapid, high-impact work accomplished in just the first three years of the NIH’s Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern program, or AViDD for short.

 “This work illustrates exactly what AViDD was designed to do — push forward innovative strategies that expand the antiviral arsenal,” Chanda said. “By showing that RNA can be systematically targeted with drug-like molecules, the team has opened doors for medicines against many viruses, not just SARS-CoV-2.”

 

END


ELSE PRESS RELEASES FROM THIS DATE:

The mouse eye as a window to spotting systemic disease

2025-10-06
A new method of taking microscopic images of a live mouse’s retina through the eye allows to record the reaction of brain cells to disease and treatment. The Kobe University development is more easily applicable than previous methods and promises to advance research on and treatment of vision-related diseases. Diabetic retinopathy, a form of diabetic eye disease, is one of the leading causes of blindness around the globe. “It’s understood that vision is lost due to damage to the blood vessels in the retina, but recent research has identified that abnormalities in neurons and immune cells begin prior to vascular damage,” says Kobe ...

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

2025-10-06
Rockville, MD. (October 6, 2025) – The 2025 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship will convene an extraordinary roster of world-renowned scientists, entrepreneurs, investors, and patient advocates on October 24, 2025, at the National Press Club in Washington, D.C. This is a signature annual gathering where the leaders driving the future of oncology come together under one roof to challenge the status quo, reveal bold ideas, share insights, and spark collaborations that shape what’s next in cancer research ...

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

2025-10-06
Key takeaways Internal organ tissues often don’t heal after illness or injury and lose some function, such as the heart after a heart attack. UCLA cardiologists have identified a protein that interferes with healing. Funded entirely by federal and state grants, the researchers developed a drug to block this protein and promote tissue regeneration. The FDA has now granted approval to begin Phase I clinical trials of the first-in-class drug for tissue repair, called AD-NP1, in humans. The body’s tissues can get injured in many ways, but while some injuries ...

Exploring the therapeutic potential of cannabidiol for Alzheimer's

2025-10-06
Neuroinflammation damages neurons and can contribute to diseases like Alzheimer’s. Cannabidiol (CBD) has anti-inflammatory properties, which suggests that it could combat neuroinflammation in Alzheimer’s. In a new eNeuro paper, Babak Baban and colleagues, from Augusta University, explored whether CBD can be leveraged as an antiinflammatory treatment in an established Alzheimer’s disease mouse model.    The researchers assessed two distinct mechanisms for shaping immune responses and regulating neuroinflammation ...

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

2025-10-06
Images Spirals of solar wind can spin off larger solar eruptions and disrupt Earth's magnetic field, yet they are too difficult to detect with our current single-location warning system, according to a new study from the University of Michigan.    But a constellation of spacecraft, including one that sails on sunlight, could help find the tornado-like features in time to protect equipment on Earth and in orbit. The study results come from computer simulations of a massive cloud of plasma erupting from the sun and moving through the solar system. Because the simulation covers features that span ...

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

2025-10-06
The selection of patients for allo-HSCT and the best approach to bridging patients to transplantation is continuously discussed by experts. The first results of the ASAP study (ASAP standing for “as soon as possible”), published in 2024, have already attracted considerable attention [2]. ASAP questions existing treatment standards for AML and was the first randomized controlled trial to compare remission induction with salvage chemotherapy prior to allo-HSCT – which represents ...

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

2025-10-06
In a recent study published in Cell Metabolism, a collaborative research team led by Chen-Yu Zhang, Xi Chen, and Di-Jun Chen from Nanjing University, together with Tao Zhang from Nanjing Medical University, reported groundbreaking findings in their paper entitled “Paternal exercise confers endurance capacity to offspring through sperm microRNAs.” This research provides the first evidence that sperm microRNAs act as carriers of epigenetic information, enabling the intergenerational transmission of paternal ...

Seeing double: Clever images open doors for brain research

2025-10-06
New artificial intelligence-generated images that appear to be one thing, but something else entirely when rotated, are helping scientists test the human mind. The work by Johns Hopkins University perception researchers addresses a longstanding need for uniform stimuli to rigorously study how people mentally process visual information. “These images are really important because we can use them to study all sorts of effects that scientists previously thought were nearly impossible to study in isolation—everything from size to animacy to emotion,” said ...

Inhaler-related greenhouse gas emissions in the US

2025-10-06
About The Study: Inhaler-related emissions in the U.S. have increased over the past decade. Policymakers and regulators seeking to reduce emissions should identify targeted solutions aimed at shifting utilization to currently marketed dry powder and soft mist inhalers while facilitating the entry of newer, affordable metered-dose products containing propellants with low global warming potential. Corresponding Author: To contact the corresponding author, William B. Feldman, MD, DPhil, MPH, email wfeldman@mednet.ucla.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2025.16524) Editor’s ...

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

2025-10-06
Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study — the largest to date quantifying inhaler-related emissions in the United States. Researchers found that inhalers have generated over 2 million metric tons of carbon emissions annually over the past decade, equivalent to the emissions of roughly 530,000 gas-powered cars on the road each year. The study, published in JAMA, analyzed emissions from the three types of inhalers approved for asthma or COPD from 2014 to 2024. It found that metered-dose inhalers were the most ...

LAST 30 PRESS RELEASES:

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Exploring the therapeutic potential of cannabidiol for Alzheimer's

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

Seeing double: Clever images open doors for brain research

Inhaler-related greenhouse gas emissions in the US

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

A surgical handover system for patient physiology and safety

Cardiovascular health changes in young adults and risk of later-life cardiovascular disease

Nurse workload and missed nursing care in neonatal intensive care units

How to solve the remote work stalemate – dissertation offers tools for successful hybrid work

Chip-based phonon splitter brings hybrid quantum networks closer to reality

Texas Children’s researchers create groundbreaking tool to improve accuracy of genetic testing

Milken Institute, Ann Theodore Foundation announce more than $2.5 million in new funding for sarcoidosis research and launch new call for proposals

Boston University professor to receive 2025 Eugene Braunwald Academic Mentorship Award

Pusan National University researchers reveal how forest soil properties influence arsenic mobility and toxicity in soil organisms

Korea University researchers find sweet taste cells resist nerve damage through c-Kit protein

HealthFORCE, AAPA, and West Health release “Aging Well with AI” – first in a two part series on AI and the healthcare workforce

The real reasons Endurance sank — study finds Shackleton knew of ship’s shortcomings

Marine heatwaves have hidden impacts on ocean food webs and carbon cycling

[Press-News.org] Scientists blaze new path to fighting viral diseases
Mapping vulnerabilities in the SARS-CoV-2 genome, made of RNA, reveals a path to fighting more than COVID-19